Cancer News and Research

Latest Cancer News and Research

U.S. News recognizes U of U as No. 1 health care system in Salt Lake City metro area

University of Utah Health Care is the No. 1 health care system in the Salt Lake City metro area, according U.S. News & World Report's 2011-2012 Best Hospitals rankings.

20 Jul 2011

Cord Blood Bank of Arkansas opens at UAMS

Celebrating the grand opening of the Cord Blood Bank of Arkansas at the University of Arkansas for Medical Sciences (UAMS) today, Brian and Jennifer Odle told how the use of cord blood gave their 18-month-old daughter a new lease on life.

20 Jul 2011

U.S. News ranks Mount Sinai Medical Center among America's Best Hospitals for 2011-2012

Mount Sinai Medical Center is among the nation's top hospitals for the fifth year in a row according to U.S. News & World Report's 2011-2012 Best Hospitals. Mount Sinai was the only hospital in South Florida to receive a prestigious national ranking in geriatric care and one of only three hospitals in South Florida to rank on a national level.

20 Jul 2011

Medco announces new offerings within Advanced Oncology Solutions

Medco Health Solutions, Inc. today announced new offerings within its Advanced Oncology Solutions, that include treatment pathways decision support with embedded pharmacogenomic testing and nutrition recommendations for cancer patients.

20 Jul 2011

Chemotherapy combined with anti-cancer agent shows promise for treatment of aggressive breast cancers

Some of the most aggressive forms of breast cancer are more vulnerable to chemotherapy when it is combined with a new class of anti-cancer agent, researchers from the Walter and Eliza Hall Institute have shown.

20 Jul 2011

U.S. News provides top rankings to five UVA Health System specialties

Five medical specialties at the University of Virginia Health System are ranked among the top in their field in U.S. News & World Report's annual "Best Hospitals" guide.

20 Jul 2011

Normal stem cell encourages growth of cancer stem cells and fuels ovarian cancer

Researchers at the University of Michigan Comprehensive Cancer Center have found that a type of normal stem cell fuels ovarian cancer by encouraging cancer stem cells to grow.

20 Jul 2011

Hallmark of cancer cells

Scientists from the Hebrew University have identified the molecular basis for DNA breakage, a hallmark of cancer cells. The findings of this research have just been published in the journal Molecular Cell.

20 Jul 2011

PCPCC coalition to trace progress of medical home at Oct. 21, 2011 Summit

Five short years ago, the patient centered medical home was a little-known model with the promise to improve patient outcomes and transform health care delivery. In October, the Patient-Centered Primary Care Collaborative will trace the progress of the medical home in the context if its own five-year history of stakeholder collaboration focused on continued advancement of what is now the rapidly expanding medical home concept.

20 Jul 2011

Study reveals how alcohol and weight influence breast cancer hormone levels in post menopausal women

Weight is the biggest factor affecting the level of sex hormones that increase breast cancer risk in post menopausal women, according to new research published in the British Journal of Cancer today (Wednesday).

20 Jul 2011

Birth control pills may reduce woman's bone density

Birth control pills may reduce a woman's bone density, according to a study published online July 13 in The Journal of Clinical Endocrinology and Metabolism by Group Health Research Institute (GHRI) scientists.

20 Jul 2011

Possible new drug targets for treating diffuse large B-cell lymphoma

Researchers at the University of Maryland School of Medicine have discovered a novel interaction between two proteins involved in regulating cell growth that could provide possible new drug targets for treating diffuse large B-cell lymphoma, the most common type of non-Hodgkin's lymphoma.

20 Jul 2011

New transgenic mouse could predict toxicity of targeted cancer drugs

Only one in twenty cancer drugs makes its way from the laboratory to become an approved pharmaceutical product. The majority of new agents are only shown to be unsuitable in the later phases of clinical development which would explain the exorbitantly high development costs of 500 to 600 million euros per new cancer drug.

20 Jul 2011

Millennium submits VELCADE sNDA to FDA to add OS data for previously untreated multiple myeloma

Millennium: The Takeda Oncology Company with its parent company Takeda Pharmaceutical Company Limited today announced the submission of a supplemental New Drug Application (sNDA) with the U.S. Food and Drug Administration for VELCADE® (bortezomib) for injection to add overall survival data after a five-year follow up to the product label.

20 Jul 2011